Search

everythinglearnresearchcommunity

for

Search:↓

ODAC members faced intense pressure but prioritized scientific evidence in drug approval decisions.

GnRH agonists can help manage recurrent priapism in sickle cell patients, but long-term safety is unclear.

Androgenetic alopecia involves immune cell disruptions, especially increased CD4+ T cells around hair follicles.

In post-menopausal women, signs of increased male hormones should be checked for possible ovarian cancer.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

Provenge extends prostate cancer survival by about 4 months.

Hair loss can be treated with common methods like minoxidil and finasteride, but new potential treatments include growth factors, cytokines, and platelet-rich plasma injections.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

Lifestyle changes, exercise, and antioxidants can help manage polycystic ovary syndrome.

Cancer risk is linked to the balance of mutations and environmental factors, not just the number of mutations.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

Higher cell number PRP improves hair density and diameter more than lower cell number PRP.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Genomic profiling for myeloid cancers can find important inherited mutations, but it's challenging when these mutations aren't related to the patient's symptoms.

Cold Atmospheric Plasma shows promise in treating aggressive breast cancer by targeting cancer cells while sparing normal tissue.

Stem cells have great potential for treating various medical conditions.

Improved oral hygiene and dietary changes can help manage black hairy tongue syndrome.

Some rules should be enforced after acceptance, but funding and conflict of interest must be addressed before peer review for ethical integrity.

Many pediatric epilepsy patients experience preventable severe adverse drug reactions, especially with certain medications and risk factors.

Childhood cancer survivors need better skin care and sun protection.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

New therapies and trials are needed for Merkel cell carcinoma, a tough skin cancer.

Low iron levels can cause hair loss and restless legs in non-anemic women.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

Data-driven methods can effectively identify existing drugs for new uses, especially in cancer, infections, and respiratory diseases.

Reporter characteristics affect detection of hair loss from cancer therapy.

Eyebrow follicles are best for accurate genetic testing after stem cell transplants.

Accurate ANA testing is crucial for early lupus diagnosis and treatment.